FNArena Windows

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

ASX CODE LAST PRICE % MOVE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET UPSIDE/DOWNSIDE
4DX $3.80

7.34%

$7.55 $1.40 -65.3

$4.50

18.4%

ACL $2.88

1.41%

$3.03 $1.83 15.4

$2.65

-8.0%

ACR $0.01 0.00% $0.02 $0.01

ACW $0.06 0.00% $0.07 $0.03

ADO $0.02 0.00% $0.05 $0.01

AFP $3.54

3.21%

$4.13 $2.30

AGN $0.15 0.00% $0.35 $0.09

ALC $0.10 0.00% $0.14 $0.08 50.0

$0.15

50.0%

ARX $0.53

-1.85%

$0.80 $0.50 35.9

$0.94

77.4%

AT1 $0.02 0.00% $0.05 $0.02

ATH $0.42

-2.33%

$0.79 $0.01

AVE $0.02 0.00% $0.03 $0.01

AVH $2.96

6.09%

$3.08 $1.00

$2.95

-0.3%

AYA $3.64 0.00% $6.49 $2.12

$6.00

64.8%

BB1 $0.69

1.47%

$1.11 $0.51

$1.76

155.1%

BIO $0.43

10.26%

$0.53 $0.20 26.9

$0.75

74.4%

BMT $0.11 0.00% $0.24 $0.08

BOT $0.02 0.00% $0.17 $0.02

BRN $0.13 0.00% $0.27 $0.11

CAT $2.91 0.00% $7.72 $2.74

$5.16

77.3%

CBL $0.06 0.00% $0.10 $0.03

CGS $3.29

3.13%

$3.38 $1.75 24.7

$3.70

12.5%

CMP $0.23 0.00% $0.45 $0.22

COH $136.39

-0.62%

$296.91 $88.74 26.1

$138.537

1.6%

COV $0.33

3.17%

$0.90 $0.29

CSL $177.56

1.81%

$222.47 $90.00 20.0

$167.673

-5.6%

CSX $0.40

8.22%

$0.78 $0.32

CTE $1.17

-0.85%

$1.40 $0.80

CU6 $2.10

0.48%

$5.87 $1.80

$6.40

204.8%

CUV $8.16

0.37%

$13.48 $7.93 12.5

$10.75

31.7%

CVB $0.03

45.45%

$0.13 $0.02

DOC $0.12 0.00% $0.20 $0.11 12.7

$0.22

78.9%

DXB $0.25

4.26%

$0.67 $0.16

EBO $16.31

0.12%

$26.75 $15.68 13.5

$23.81

46.0%

EBR $0.25 0.00% $1.47 $0.24

$1.275

420.4%

EGH $0.65

4.88%

$0.80 $0.45 16.5

$0.85

31.8%

EIQ $0.59

13.46%

$1.88 $0.17

$0.983

66.6%

EMV $1.65

-5.19%

$2.16 $1.47

$3.15

91.5%

EYE $0.14 0.00% $0.21 $0.10

FPH $35.55

-0.03%

$37.71 $26.51 44.7

GSS $0.07

-13.16%

$0.43 $0.05

$0.10

51.5%

HLS $0.45 0.00% $1.07 $0.30

$0.48

7.9%

IDT $0.05 0.00% $0.07 $0.03

IDX $2.32

-0.85%

$2.97 $1.91 17.7

$3.375

45.5%

ILA $0.42

-2.33%

$0.63 $0.31

IME $0.30

-6.25%

$0.47 $0.23

$0.37

23.3%

IMM $0.05 0.00% $0.47 $0.03

$0.06

33.3%

IMR $1.80

-1.64%

$2.25 $1.28

$2.90

61.6%

IMU $0.05 0.00% $0.46 $0.05

$0.25

431.9%

INA $4.17

2.46%

$5.88 $3.49 11.2

$4.89

17.3%

IPD $0.01 0.00% $0.06 $0.00

$0.015

200.0%

IVX $0.05 0.00% $0.12 $0.03

LDX $0.11 0.00% $0.33 $0.08

$0.25

138.1%

LGP $0.07 0.00% $0.15 $0.06

LIC $4.73

0.64%

$6.16 $4.47 22.3

$5.588

18.1%

M7T $0.23

4.55%

$0.69 $0.22

$0.48

108.7%

MAP $0.05 0.00% $0.11 $0.04

$0.085

60.4%

MPL $4.61

-0.22%

$5.31 $4.06 18.3

$5.214

13.1%

MSB $2.06

0.98%

$3.31 $1.88 29.2

$4.45

116.0%

MVF $0.79

2.60%

$0.90 $0.58 16.3

$0.807

2.2%

MVP $0.49

-2.02%

$0.77 $0.37 121.3

$1.00

106.2%

MX1 $0.02 0.00% $0.12 $0.01

$0.06

252.9%

MYX $3.02

0.67%

$6.50 $2.04

NAN $2.89 0.00% $4.76 $2.64 74.1

$3.633

25.7%

NEU $20.54

0.88%

$23.76 $11.00 52.3

$25.867

25.9%

NHF $6.55

-0.30%

$7.73 $5.79 14.4

$7.36

12.4%

NUZ $0.08 0.00% $0.17 $0.05

$0.20

150.0%

OCA $0.53 0.00% $0.82 $0.52

OCC $0.70 0.00% $1.60 $0.67

$1.13

62.6%

ONE $0.16

-5.88%

$0.41 $0.13

$0.42

162.5%

OSL $0.97 0.00% $2.09 $0.37

PAR $0.25 0.00% $0.47 $0.14

$0.42

68.0%

PCK $0.12 0.00% $0.35 $0.04

PEB $0.21 0.00% $0.27 $0.12

PER $0.00 0.00% $0.01 $0.00

PGC $0.14 0.00% $0.33 $0.13 7.9

$0.23

70.4%

PME $169.22

2.37%

$321.57 $107.75 85.2

$225.833

33.5%

PNV $0.95

-1.05%

$1.66 $0.81 60.3

$1.21

28.0%

PYC $2.40

6.67%

$2.62 $0.90

$3.55

47.9%

RAC $2.02

-0.49%

$4.90 $1.91

RAP $0.02 0.00% $0.07 $0.02

RCE $0.34 0.00% $0.73 $0.32

REG $4.80

4.12%

$9.40 $3.85 25.9

$5.95

24.0%

RHC $55.13

0.51%

$55.98 $30.39 31.8

$49.682

-9.9%

RMD $32.04

0.44%

$43.29 $25.50 18.3

$38.875

21.3%

RYM $1.58

-4.26%

$2.64 $1.54

SHG $0.18

-5.26%

$0.35 $0.17

SHL $19.62

0.41%

$24.27 $18.26 15.9

$22.543

14.9%

SLD $0.42 0.00% $1.56 $0.36

$1.885

354.2%

SNT $0.02 0.00% $0.04 $0.02

$0.06

160.9%

SNZ $6.20

1.47%

$12.09 $5.75 7.4

SOM $0.35

2.94%

$0.95 $0.30 15.2

$0.76

117.1%

SPL $0.77

1.32%

$0.83 $0.12

TLX $17.45

3.44%

$18.32 $8.26 274.4

$23.29

33.5%

TRJ $0.18

12.90%

$0.87 $0.15 5.6

$0.55

214.3%

TRP $0.08 0.00% $0.48 $0.06

VIT $0.02 0.00% $0.07 $0.02

ZNO $0.06 0.00% $0.18 $0.03

Previous Stories
Treasure Chest: CSL Not A One-Trick Pony

Jul 14 2025

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on CSL


Strength To ‘AI’ Strength For Pro Medicus

Jul 10 2025

Pro Medicus shares surge on major contract wins and growing AI momentum, reinforcing its position as a high-margin healthcare tech leader against a background of eternal valuation debate


The Enigma Surrounding Clinuvel

Jul 03 2025

Clinuvel Pharmaceuticals posted a strong first half result, and offers significant upside in expanding the use of its flagship drug, but investors just aren’t excited


Better Times Ahead For Sonic Healthcare?

Jun 20 2025

New research coverage on Sonic Healthcare suggests better times are ahead, supplemented by new technologies including artificial intelligence and genetic engineering


Cochlear Downgrades Ahead Of New Launches

Jun 19 2025

A decline in Services revenue had led to another profit downgrade from Cochlear, but brokers look ahead to new product launches


Fisher & Paykel Healthcare’s Tariffs Annoyance

Jun 04 2025

A consensus-beating FY25 result from Fisher & Paykel Healthcare was undermined by disappointing FY26 guidance, with tariffs partly to blame


Rudi’s View: CSL & NextDC

May 08 2025

Your Editor attended presentations by CSL and NextDC this week


ResMed’s Margin Expansion & Tariff Exemption

Apr 28 2025

ResMed’s largely in-line third quarter results showcased a rising gross margin, while management also moved to ease market concerns regarding tariffs


SMSFundamentals: Should You Sell Your Home To Buy Your Nursing ‘Home’?

Apr 24 2025

Selling the family home is sometimes the most advantageous decision to make


In Brief: Tariffs, Healthcare & Wealth Platforms

Apr 11 2025

Weekly Broker Wrap: Looking through the market chaos of will he (Trump), won’t he on tariffs, analysts dissect the pros and cons of earnings fundamentals versus share prices